| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/31/2006 | US20060194295 Novel, esterase, fungus capable of producing the same and method for producing the same |
| 08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
| 08/31/2006 | US20060194292 Contains insulin-like growth factor-I, insulin-like growth factor binding protein 3 and integrin-binding domain of vitronectin ; wound healing; surgical implant, prosthesis, scaffold, wound or burn dressing |
| 08/31/2006 | US20060194291 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 08/31/2006 | US20060194290 Polypeptide variants with altered effector function |
| 08/31/2006 | US20060194289 Method of production of recombinant proteins in eukaryote cells |
| 08/31/2006 | US20060194288 Nucleic acid molecules encoding endonucleases and methods of use thereof |
| 08/31/2006 | US20060194287 Chemokine-binding protein and methods of use |
| 08/31/2006 | US20060194286 Apo-2LI and Apo-3 polypeptides |
| 08/31/2006 | US20060194285 Biological production of clavulanic acid and related compounds |
| 08/31/2006 | US20060194284 Recombinant co-expression of vitamin K epoxide reductase subunit 1 to improve vitamin K dependent protein expression |
| 08/31/2006 | US20060194283 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194282 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 08/31/2006 | US20060194281 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents |
| 08/31/2006 | US20060194280 Methods for refolding of recombinant antibodies |
| 08/31/2006 | US20060194279 Protein-refolding material |
| 08/31/2006 | US20060194278 Process for producing glucose dehydrogenase |
| 08/31/2006 | US20060194277 Method for producing target proteins by deleting or amplifyingibpa and/or ibpb gene coding for inclusion body-associated proteins |
| 08/31/2006 | US20060194276 Specificity grafting of a murine antibody onto a human framework |
| 08/31/2006 | US20060194275 Transporter and ion channels |
| 08/31/2006 | US20060194265 Novel therapeutic targets in cancer |
| 08/31/2006 | US20060194257 MECP2E1 gene |
| 08/31/2006 | US20060194254 Method for identifying optimal binding ligands to a receptor |
| 08/31/2006 | US20060194253 A transfected cell line and a method using the same for the high throughput screening for inhibitors of the t-type calcium channel alpha-1h |
| 08/31/2006 | US20060194233 Ligand of the protein "beacon" |
| 08/31/2006 | US20060194219 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194218 Inducible fluorescence assay |
| 08/31/2006 | US20060194210 Novel therapeutic targets in cancer |
| 08/31/2006 | US20060194204 Gene expressed in prostate cancer, methods and use thereof |
| 08/31/2006 | US20060193930 Process for the preparation of protein hydrolysate from legumes |
| 08/31/2006 | US20060193874 Vaccines for proliferative ileitis and methods of making and using the same |
| 08/31/2006 | US20060193870 Compositions and methods for the therapy and diagnosis of colon cancer |
| 08/31/2006 | US20060193867 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 08/31/2006 | US20060193866 H pylori antigens |
| 08/31/2006 | US20060193861 Tumor necrosis factor receptors 6 alpha & 6 beta |
| 08/31/2006 | US20060193859 Methods of Treatment Using Antibodies to Neutrokine-alpha |
| 08/31/2006 | US20060193858 Full-lenth, isolated polypeptide comprising a polypeptide sequence of human SRC-like adaptor protein |
| 08/31/2006 | US20060193856 Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof |
| 08/31/2006 | US20060193855 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/31/2006 | US20060193851 Human anti-factor IX/IXa antibodies |
| 08/31/2006 | US20060193848 Mammalian tumor susceptibility genes and their uses |
| 08/31/2006 | US20060193772 Drugs for treating cancer |
| 08/31/2006 | CA2785161A1 Mutant aox 1 promoters |
| 08/31/2006 | CA2642911A1 Circular permutant gfp insertion folding reporters |
| 08/31/2006 | CA2599606A1 Bispecific binding agents for modulating biological activity |
| 08/31/2006 | CA2598823A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 08/31/2006 | CA2569381A1 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 08/30/2006 | EP1696234A1 Methods using O6-alkylguanine-DNA alkyltransferases |
| 08/30/2006 | EP1696035A2 Improved bacillus host cell |
| 08/30/2006 | EP1696031A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1696027A1 Hla-dr-binding antigen peptide derived from wt1 |
| 08/30/2006 | EP1695986A2 Anti-erb B2 antibodies |
| 08/30/2006 | EP1695985A2 Humanized antibodies and methods for forming humanized antibodies |
| 08/30/2006 | EP1695982A1 Glycosylation-deficient hepatocyte growth factor |
| 08/30/2006 | EP1694846A1 A cell with improved secretion mediated by mrga protein or homologue |
| 08/30/2006 | EP1694703A1 Process for purifying interferon beta |
| 08/30/2006 | EP1694694A2 Replication competent hepatitis c virus and methods of use |
| 08/30/2006 | EP1497444A4 Methods for increasing polypeptide production |
| 08/30/2006 | EP1423524B1 Method of protein production in plants |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1171604B1 Dna sequence and recombinant production of a graminae allergen |
| 08/30/2006 | EP1133558B1 Compositions and methods for increasing bone mineralization |
| 08/30/2006 | EP1037900A4 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 08/30/2006 | EP1015596B1 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 08/30/2006 | EP0972036B1 Prion propagation inhibition by dominant-negative prion protein mutants |
| 08/30/2006 | EP0909316B1 Glial cell line-derived neurotrophic factor receptor |
| 08/30/2006 | EP0728200B1 Haemophilus transferrin receptor genes |
| 08/30/2006 | EP0529033B1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/30/2006 | CN1826413A Method for producing dipeptides |
| 08/30/2006 | CN1826412A Modified starch, uses, methods for production thereof |
| 08/30/2006 | CN1826355A Monoclonal antibody against influenza B virus and immunoassay instrument using the antibody |
| 08/30/2006 | CN1826350A Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 08/30/2006 | CN1824789A Preparation of testis specific protein 50 monoclonal antibody and polyclonal antibody and use |
| 08/30/2006 | CN1824788A Process for preparing pepton |
| 08/30/2006 | CN1824787A Process for preparing peptone |
| 08/30/2006 | CN1824777A Human g-protein coupled receptor |
| 08/30/2006 | CN1824775A Preparation technology of recombination human blood vessel inhibitor K1-3 and its application in medicine for treating tumour |
| 08/30/2006 | CN1824771A Bone marrow matrix cell transfectioned by human promoting blood vascular poietin gene and its use |
| 08/30/2006 | CN1824680A BMP2/7 allodiploid structure analogue, its expression method and application |
| 08/30/2006 | CN1824673A Cytoplasm film marked compound and its preparation method |
| 08/30/2006 | CN1824292A Medicine for improving brain function its preparation method and use |
| 08/30/2006 | CN1824287A Preparation technology of liver hydrolytic peptide injection liquid |
| 08/30/2006 | CN1272345C Silensed anti-CD 28 antibodies and use thereof |
| 08/29/2006 | US7098323 Polynucleotide squences and amino acid sequences for diagnosis of diseases and growth factors |
| 08/29/2006 | US7098318 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity |
| 08/29/2006 | US7098317 Antibodies capable to selectively detect prion PrPSc isoforms |
| 08/29/2006 | US7098311 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferative disorders |
| 08/29/2006 | US7098303 Immunogenic polypeptide; vaccine for therapy of HCV infection and assays for the diagnosis of HCV |
| 08/29/2006 | US7098185 Comprises matrix extracellular phosphoglycoprotein (MEPE) for diagnosing and treating rickets, urogenital, kidney and bone disorders |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 08/29/2006 | US7098183 cell growth differentiation factors/polypeptides for immunization; animal models |
| 08/29/2006 | US7098036 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 08/29/2006 | US7098031 Random integration of a polynucleotide by in vivo linearization |
| 08/29/2006 | US7098025 Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor |
| 08/29/2006 | US7098024 Depsipeptide compound |
| 08/29/2006 | US7098018 used to produce recombinant human growth hormone |
| 08/29/2006 | US7098013 used for formation of cyclotetrasaccharide from a saccharide with a glucose polymerization degree of 3 or higher; genetic engineering |